FME — Fresenius Medical Care AG Income Statement
0.000.00%
Last trade - 00:00
- €10.40bn
- €22.01bn
- €19.45bn
- 84
- 80
- 31
- 75
2019 December 31st | 2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17,477 | 17,859 | 17,619 | 19,398 | 19,454 |
Cost of Revenue | |||||
Gross Profit | 5,396 | 5,537 | 4,773 | 4,894 | 4,925 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15,207 | 15,555 | 15,766 | 17,886 | 18,084 |
Operating Profit | 2,270 | 2,304 | 1,852 | 1,512 | 1,369 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,840 | 1,936 | 1,572 | 1,219 | 1,033 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,439 | 1,436 | 1,219 | 894 | 732 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,200 | 1,164 | 969 | 673 | 499 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,200 | 1,164 | 969 | 673 | 499 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.2 | 4.72 | 3.38 | 2.15 | 2.91 |
Dividends per Share |